Pazufloxacin Mesylate (CAS 163680-77-1)

Pazufloxacin Mesylate (CAS 163680-77-1) 参考文献

1. 甲磺酸帕珠沙星对茶碱血清浓度的影响  |  Niki, Y., et al. 2002. J Infect Chemother. 8: 33-6. PMID: 11957117
2. [新型注射用喹诺酮类药物甲磺酸帕珠沙星的体外和体内抗菌活性]。  |  Nomura, N., et al. 2002. Jpn J Antibiot. 55: 412-39. PMID: 12378871
3. [注射用新型喹诺酮类抗生素甲磺酸帕珠沙星的药理特性和预期临床作用]。  |  Minami, S., et al. 2003. Nihon Yakurigaku Zasshi. 122: 161-78. PMID: 12890902
4. 测定甲磺酸帕珠沙星的铽敏化荧光法及其应用。  |  Chen, S., et al. 2004. Anal Sci. 20: 1075-8. PMID: 15293405
5. [静脉注射新型喹诺酮类抗菌药甲磺酸帕珠沙星对 QT 间期的影响]。  |  Fukuda, H., et al. 2004. Jpn J Antibiot. 57: 404-12. PMID: 15535041
6. 甲磺酸帕珠沙星对军团病的疗效：一份病例报告和对分离物的体外研究。  |  Higa, F., et al. 2005. J Infect Chemother. 11: 164-8. PMID: 15990982
7. 用于甲磺酸帕珠沙星控制给药的戊二醛交联 O-羧甲基壳聚糖微球的制备与表征  |  Liu, YF., et al. 2007. Int J Biol Macromol. 41: 87-93. PMID: 17292465
8. 头孢哌酮和阿奇霉素对大鼠帕珠沙星药代动力学的影响  |  Lou, S., et al. 2007. Eur J Drug Metab Pharmacokinet. 32: 219-23. PMID: 18348471
9. [甲磺酸帕珠沙星注射液的临床药代动力学/药效学研究]。  |  Wang, XG., et al. 2009. Sichuan Da Xue Xue Bao Yi Xue Ban. 40: 689-93. PMID: 19764574
10. [采用蒙特卡罗模拟法评估甲磺酸帕珠沙星的达标率]。  |  Abe, N., et al. 2010. Jpn J Antibiot. 63: 319-25. PMID: 21298865
11. 甲磺酸帕珠沙星在氨基功能化碳纳米管上的吸附行为  |  Jiang, L., et al. 2012. J Nanosci Nanotechnol. 12: 7271-9. PMID: 23035463
12. 基于生物分子稳定金纳米团簇的荧光探针，用于检测甲磺酸帕珠沙星。  |  Cao, X., et al. 2014. Anal Sci. 30: 817-22. PMID: 25109644
13. 重复口服甲磺酸帕珠沙星和美洛昔康对兔子抗氧化状态的影响  |  Khan, AM. and Rampal, S. 2014. J Am Assoc Lab Anim Sci. 53: 399-403. PMID: 25199097
14. 基于金纳米粒子聚集的甲磺酸帕珠沙星比色法识别。  |  Kong, S., et al. 2016. Spectrochim Acta A Mol Biomol Spectrosc. 157: 244-250. PMID: 26774816